NARA Discovery
Article Details
← Back to Search Results
Journal Article

Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir

Lea Patasic; Janna Seifried; Valerie Bezler; Marcell Kaljanac; Irene C. Schneider; Heike Schmitz; Christiane Tondera; Jessica Hartmann; Andreas Hombach; Christian J. Buchholz; Hinrich Abken; Renate König; Klaus Cichutek
Medical Microbiology and Immunology · Vol. 209, Issue 6 · pp. 681-691 · 2020

Abstract

Chimeric Antigen Receptor (CAR)-redirected T cells show great efficacy in the patient-specific therapy of hematologic malignancies. Here, we demonstrate that a DARPin with specificity for CD4 specifically redirects and triggers the activation of CAR engineered T cells resulting in the depletion of CD4 + target cells aiming for elimination of the human immunodeficiency virus (HIV) reservoir.

Bibliographic Information

JournalMedical Microbiology and Immunology
PublisherSpringer
Publication Date2020-12-01
Publication Year2020
Volume209
Issue6
Pages681-691
Document TypeJournal Article
Print ISSN0300-8584
eISSN1432-1831
DOI10.1007/s00430-020-00692-0

Access Information

NARA Access Coverage1886-01-01~Current
Journal Homepagehttps://www.springer.com/journal/430
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.